Sign in

CIK 0001410098

  • Non-accelerated filer

CorMedix Inc.

Sign in to watch
Ticker
CRMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 908-517-9500
Business address
389 INTERPACE PKWY, SUITE 450, PARSIPPANY, NJ, 07054
Open-market buys, last 90 days
$588,195
in 4 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$588,195. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-01-10 Dillione Janet Director Grant or award · Stock Option (Right to Buy Common Stock) +75,000 75,000
2018-12-31 ARMSTRONG JR. JOHN L. Exec VP of Tech Operations Exercise or conversion +18,029 306,890
2018-12-31 ARMSTRONG JR. JOHN L. Exec VP of Tech Operations Exercise or conversion · Restricted Stock Units −18,029 0
2018-12-20 Lefkowitz Steven W Director Purchase +20,000 $1.18 $24K 135,757
2018-12-20 Khan Mehmood Director Purchase +100,000 $1.24 $124K 564,583
2018-12-14 Kaplan Myron Director Purchase +50,000 $1.47 $73K 431,166
2018-12-05 Masson Elizabeth EVP, Head of Clinical Ops. Exercise or conversion +40,000 $0.29 $12K 40,000
2018-12-05 Masson Elizabeth EVP, Head of Clinical Ops. Exercise or conversion · Stock Option (Right to Buy Common Stock) −40,000 270,000
2018-11-29 ARMSTRONG JR. JOHN L. Exec VP of Tech Operations Purchase +250,000 $1.45 $363K 288,861
2018-11-27 Baluch Khoso Chief Executive Officer Purchase +21,500 $1.21 $26K 250,373
2018-11-27 Cook Robert W. Chief Financial Officer Purchase +25,000 $1.17 $29K 127,083
2018-11-26 Baluch Khoso Chief Executive Officer Purchase +3,500 $1.28 $4K 228,873
2018-11-23 Kaplan Myron Director Purchase +50,000 $1.30 $65K 371,166
2018-11-14 Dillione Janet Director Grant or award · Phantom Stock +6,637 $1.13 $7K 6,637
2018-11-14 Dillione Janet Director Grant or award · Phantom Stock +6,637 $1.13 $7K 6,637
2018-11-06 Kaplan Myron Director Exercise or conversion +5,000 321,166
2018-11-06 Kaplan Myron Director Exercise or conversion · Restricted Stock Units −5,000 0
2018-10-12 Gelbfish Gary A. Director Exercise or conversion +1,000,000 $1.05 $1.1M 3,111,121
2018-10-12 Gelbfish Gary A. Director Shares withheld for taxes −468,750 $2.24 $1.1M 2,642,371
2018-10-12 Gelbfish Gary A. Director Exercise or conversion · Series B Common Stock Warrant −1,000,000 0

Page 17 of 24 · 463 trades